Статус неизвестен
Фаза II
Россия
XC243 25 mg; XC243 50 mg; XC243 75 mg; Placebo · PHARMENTERPRISES LLC
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis